Alzheimer Disease as a Clinical-Biological Construct—An International Working Group RecommendationBruno Dubois, Giovanni B. Frisoni, Nicolas Villain et al.|JAMA Neurology|2024Cited by 355
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: LaurietCecília Monteiro, William Alvin McElveen, Seema Datta et al.|Neurology|2023Cited by 104